NextCure
NXTC
59 hedge funds and large institutions have $64.3M invested in NextCure in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 15 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
0.36% less ownership
Funds ownership: 4.34% → 3.98% (-0.36%)
5% less call options, than puts
Call options by funds: $246K | Put options by funds: $258K
17% less funds holding
Funds holding: 71 → 59 (-12)
25% less capital invested
Capital invested by funds: $86.2M → $64.3M (-$21.9M)
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$773K |
| 2 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$652K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$261K |
| 4 |
Goldman Sachs
New York
|
+$208K |
| 5 |
Renaissance Technologies
New York
|
+$204K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$3.1M |
| 2 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$2.44M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.11M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$755K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$692K |
NXTC Hedge Fund Activity: Q1 2022 in Review
59 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2022, worth a combined $64.3M — down 25% from $86.2M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of NXTC and 3 opened new positions — a net loss of 12 holders — while 16 trimmed existing stakes and 22 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $773K. The largest seller was Woodline Partners, cutting an estimated $3.1M.
- 59 institutional investors held NextCure (NXTC) as of Q1 2022, down from 71 in Q4 2021.
- Funds reported $64.3M of NextCure stock for Q1 2022, down 25% quarter-over-quarter.
- 3 funds opened new NextCure positions in Q1 2022 and 15 closed out, a net change of -12 holders.
- The largest NextCure buyer in Q1 2022 was Dimensional Fund Advisors, an estimated $773K added.
- The largest NextCure seller in Q1 2022 was Woodline Partners, an estimated $3.1M sold.
Based on aggregated 13F filings for Q1 2022.